Valproate in Late Life Schizophrenia
Completed · Phase 4
Conditions studied: Schizophrenia
In brief
The purpose of this research study is to analyze the effectiveness and tolerability of a medication, valproate ( Depakote and Depakote ER), in individuals age 50 years and older who have schizophrenia.
Key facts
- Study ID
- NCT00194025
- Run by
- University Hospitals Cleveland Medical Center
- People needed
- 20
- Starts
- 2004-11-01
- Expected to finish
- 2006-11-01
- Last updated by the study team
- 2015-01-06
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must have a diagnosis of schizophrenia as confirmed by the MINI
- Must be on antipsychotic medication
- Must be age 50 year or older
- Must be capable of providing written informed consent for study participation. In situations where individuals have guardians of person, guardian and subject must both provide written consent; and
- Must live in the Northeast Ohio area.
You may not qualify if…
- A primary psychiatric DSM Axis I diagnosis other than schizophrenia
- Actively abusing substances; or
- Medically unstable.
Where it is running
- University Hospitals of Cleveland — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.